Tissue factor expression and tumor‐infiltrating T lymphocytes in ovarian carcinomas and their association with venous thromboembolism
article
OA: closed
CC0
AI-generated summary
This study found that higher tissue factor expression and CD8+ lymphocytes in ovarian carcinomas, particularly clear cell carcinoma, were associated with venous thromboembolism.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Ovarian cancer is a known risk factor of venous thromboembolism (VTE). Thrombogenic factor expression and lymphocytic infiltrate have been reported in endometriosis and ovarian cancers. We reviewed 30 cases of ovarian carcinomas (high grade serous carcinoma, 10; endometrioid carcinoma, 10; clear cell carcinoma (CCC), 10) and 16 endometriotic lesions. We immunohistochemically investigated the expressions of tissue factor (TF), podoplanin, P-selectin, and number of CD4 and CD8 positive lymphocytes in cancer tissue and endometriotic lesions, along with their relationship with VTE. The expression of TF was higher in CCC. The TF expression and the number of CD8 positive cells were higher in cancer tissues with VTE than in those without VTE. The podoplanin or P-selectin expression did not differ among histological types or between cases with and without VTE. Our results demonstrated a high TF expression and intraepithelial CD8 cells in CCC, which were associated with VTE. The results suggest that infiltrating lymphocytes may affect TF expression that, in turn, influences VTE.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (19)
- Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma via openalex
- <i>Endometriosis and Tissue Factor</i> via openalex
- W2007208430 via openalex
- W2053849733 via openalex
- W2057491995 via openalex
- W2061745231 via openalex
- W2072474790 via openalex
- W2105459360 via openalex
- W2115791832 via openalex
- W2460304680 via openalex
- W2754338011 via openalex
- W2786262376 via openalex
- W2802129793 via openalex
- W2911794275 via openalex
- W2943272229 via openalex
- W2943435350 via openalex
- W1821140461 via openalex
- W3029273149 via openalex
- W1971512044 via openalex
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:55.077982+00:00
License: CC0
· commercial use OK